![Robert Wills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Wills
Presidente presso
ALPHA COGNITION INC.
Patrimonio netto: 346 459 $ in data 30/09/2026
Profilo
Robert James Wills is Chairman at Milestone Pharmaceuticals, Inc. since 2020.
He is Non-Executive Chairman at Alpha Cognition, Inc. starting in 2026.
He serves as Director at Parion Sciences, Inc. since 2015, at Feldan Bio, Inc., at Go Therapeutics, Inc. since 2017, and as Independent Director at Oncternal Therapeutics, Inc. since 2019.
Former roles include Executive Chairman at GTx, Inc. from 2015 to 2019, Chairman at CymaBay Therapeutics, Inc. from 2015 to 2024, Director at Oncternal Oncology, Inc., Senior Vice President-Global Development at Johnson & Johnson from 1989 to 2015, Vice President-Alliance Management at Janssen Pharmaceuticals, Inc., and Member-Emerging Companies Section at Biotechnology Innovation Organization from 2015 to 2021.
Education includes a doctorate from The University of Texas at Austin and undergraduate and graduate degrees from the University of Wisconsin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALPHA COGNITION INC 0,15% | 21/08/2026 | 32.241 ( 0,15% ) | 290 169 $ | 30/09/2026 |
| 10/06/2026 | 65.000 ( 0,05% ) | 56 290 $ | 30/09/2026 |
Posizioni attive di Robert Wills
| Società | Posizione | Inizio |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/06/2019 |
| MILESTONE PHARMACEUTICALS INC. | Presidente | - |
| ALPHA COGNITION INC. | Presidente | 16/06/2026 |
Parion Sciences, Inc.
 Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new treatments for serious diseases in multiple therapeutic areas | Direttore/Membro del Consiglio | 01/12/2015 |
Go Therapeutics, Inc.
 Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Direttore/Membro del Consiglio | 01/09/2017 |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert Wills
| Società | Posizione | Fine |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Presidente | 22/03/2024 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01/07/2021 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Presidente | 01/06/2019 |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Robert Wills
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new treatments for serious diseases in multiple therapeutic areas | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company and manufactures pharmaceutical products | Health Technology |
Go Therapeutics, Inc.
Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
